AIDAN raises concerns over NPPA chairman's transfer

Demands that the NPPA be made into a statutory body to ensure the independence and integrity of the regulator

xffxcvxvx

Pratap Vikram Singh | March 1, 2018 | New Delhi


#AIDAN   #NPPA   #All India Drug Action Network   #National Pharmaceutical Pricing Authority  

All India Drug Action Network (AIDAN) has accused US-based multinational firms in healthcare for running a malicious campaign against National Pharmaceutical Pricing Authority (NPPA) and the transfer of its chairman Bhupendra Singh. The government move would adversely impact the NPPA's ongoing work against unethical profiteering by pharmaceutical companies, device makers and corporate hospitals, the AIDAN said in a statement.

According to a government notification issued on Wednesday, the appointments committee of the cabinet has transferred Singh to National Authority for Chemical Weapons Convention in the rank and pay of additional secretary.

"The NPPA under the governance of Injeti Srinivas (former chairman) and Singh showered tremendous leadership. Srinivas was transferred even before the completion of one year following the price regulation of critical cardiac and diabetes medicines through public interest of the DPCO. During his term, Singh has taken many positive steps to ensure affordability of medicines and medical devices that discomforted the industry," the AIDAN, a non-governmental organisation working towards increasing access and rational use of essential medicines, said. 

Notably, the NPPA undertook landmark price control of stents and knee implants. There was greater accountability to the public because of increased transparency and responsiveness to grievances of patients and the industry.

The NPPA, the AIDAN said, also saw unprecedented success in the courts with its stands vindicated by favourable judgments passed by the supreme court and high courts in most cases.

Of late, the NPPA took a proactive role in initiating monitoring of high margins charged by private hospitals in an effort to curb unethical profiteering.

"We fear that Singh's transfer in total disregard to the public interest is due to the pressure from the industry and corporate hospital lobby," the AIDAN said.

The pharmaceutical industry has long sought to undermine and weaken the NPPA in order to enable uninhibited profiteering and circumvention of the law. The recent price revise of coronary stents angered the US-based MNCs which ran a malicious campaign against the regulatory authority, the AIDAN said. 

"The final precipitating factor, we believe, was the report analysing bills of four patients and which exposed the gross overcharging and misconduct of private hospitals. In this same report, the NPPA appealed for policy intervention to correct the injustice towards patients as it had reached the limits of its mandate," the non-governmental organisation said.  

The AIDAN urged the government to reconsider its decision and allow Singh to complete his three year term at the NPPA. It also demanded that the NPPA be made into a statutory body along with fixed term periods for the chairman and leadership to ensure the independence and integrity of the regulator.

Comments

 

Other News

Covid-19: India crosses 1 crore tests milestone

India has achieved a significant milestone as the number of Covid-19 tests conducted in the country so far has crossed the 1 crore milestone. This signifies the importance accorded to widespread testing and the focussed ‘Test, Trace, Treat’ strategy with several follow-up measures taken in tand

“Practise ‘mental distancing’ to keep calm amid epidemic”

Half way through the year 2020, it has been a tough time all around the world: Covid-19 epidemic, loss of lives, economic hardships and also numerous other problems – natural disasters and political protests. Coming together, it all has mental health under immense strain. To discuss this and othe

Understanding immunity: How to boost it during Covid-19

In a first, the Department of Home Science, Sri Padmavati Mahila Visvavidayalam (Women’s University) Tirupati, Andhra Pradesh, recently organized an international webinar on “Nutrition and Immune System Support during COVID-19 Pandemic”. Speakers included eminent national and internationa

Covid-19: India’s recovery rate improves to 59.43%

Even as Unlock enters the second phase, the number of Covid-19 infections continues to rise to record levels and India remains No 4 in the worldwide list, yet there is glimmer of hope: its recovery rate is also rising in tandem. There are 1,27,864 recovered cases more than the active Covid-1

Coming soon at a station near you: private trains!

A long-debated idea is finally coming to fruition as the Indian railways has decided to join hands with the private sector, in running some train services to begin with. The ministry of railways has invited ‘request for qualifications’ (RFQ) for private participation for operatio

A place of local democracy in pandemic governance: The case of Mumbai

Democracy in India is now taken for a fact, with an unstated assumption that all our institutions are democratic and hence often our successes and more often failures are attributed to ‘democracy’. However, a key frontier where democracy remains a challenge is that of local governments and that



Archives

Current Issue

Opinion

Facebook    Twitter    Google Plus    Linkedin    Subscribe Newsletter

Twitter